Re: [DIYbio] Re: Biohacker snake-oil fraudster Aaron Traywick

On 05/03/2018 06:37 AM, David Murphy wrote:
> Curing an infectious disease simply has a different return profile to treating the symptoms of one.


The way the article by Tae Kim was worded seemed totally cold hearted, so yes that's probably how successful investors use it.
But then Kim describes analyst comments, [ analyst Salveen Richter wrote in the note to clients Tuesday. "While this proposition
carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for
sustained cash flow."]

It suggests that the really big pharma companies are being trained, (by the market -- by Wall St.), to go for the good returns,
and that won't involve gene therapies that cure.
Meanwhile, the way the FDA works, only big pharma can afford their methods, so who is left to work on gene therapies
but DIYers and small companies that sidestep or flout the rules.

--
-- You received this message because you are subscribed to the Google Groups DIYbio group. To post to this group, send email to diybio@googlegroups.com. To unsubscribe from this group, send email to diybio+unsubscribe@googlegroups.com. For more options, visit this group at https://groups.google.com/d/forum/diybio?hl=en
Learn more at www.diybio.org
---
You received this message because you are subscribed to the Google Groups "DIYbio" group.
To unsubscribe from this group and stop receiving emails from it, send an email to diybio+unsubscribe@googlegroups.com.
To post to this group, send email to diybio@googlegroups.com.
Visit this group at https://groups.google.com/group/diybio.
To view this discussion on the web visit https://groups.google.com/d/msgid/diybio/118522e9-7a16-9e70-813d-9acb09b70f3a%40industromatic.com.
For more options, visit https://groups.google.com/d/optout.